|
PDB ID |
タイトル |
公開/更新年月日 |
|
投稿 |
Iketani, S.,Forouhar, F.,Liu, H.,Hong, S.J.,Lin, F.-Y.,Nair, M.S.,Zask, A.,Huang, Y.,Xing, L.,Stockwell, B.R.,Chavez, A.,Ho, D.D. Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors |
|
|
Crystal structure of SARS-CoV-2 3CL protease in complex with MAC5576 |
2021-03-10 |
|
|
Crystal structure of SARS-CoV-2 3CL protease in complex with GC376 |
2021-03-10 |
|
|
Crystal structure of SARS-CoV-2 3CL protease in complex with compound 4 in space group P1 |
2021-03-10 |
|
|
Crystal structure of SARS-CoV-2 3CL protease in complex with compound 4 |
AUTH |
|
|
|
Newman, J.A.,Yosaatmadja, Y.,Douangamath, A.,Aimon, A.,Powell, A.J.,Dias, A.,Fearon, D.,Dunnett, L.,Brandao-Neto, J.,Krojer, T.,Skyner, R.,Gorrie-Stone, T.,Thompson, W.,von Delft, F.,Arrowsmith, C.H.,Edwards, A.,Bountra, C.,Gileadi, O. PanDDA analysis group deposition of ground-state model |
To be published |
|
PanDDA analysis group deposition of ground-state model of SARS-CoV-2 helicase |
2021-03-10 |
|
|
PanDDA analysis group deposition of ground-state model of SARS-CoV-2 main protease screened against DSI poised (Enamine), Fraglites and Peplites (Newcastle university), Mini Frags (Astex), York 3D (York university), electrophile cysteine covalent (Weizman institute) fragment libraries |
2020-04-01/2021-01-27 |
|
|
PanDDA analysis group deposition of ground-state model of SARS-CoV-2 Nsp3 macrodomain |
2021-01-13/2021-01-27 |
|
|
PanDDA analysis group deposition of ground-state model of SARS-CoV-2 Nsp3 macrodomain |
2021-01-13/2021-01-27 |
|
|
投稿 |
Li D, Edwards RJ, Manne K, Martinez DR, Schäfer A [..] Haynes BF, Saunders KO. The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates |
|
|
Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052 |
2021-03-10 |
|
|
投稿 |
Yan R, Wang R, Ju B, Yu J, Zhang Y, Liu N, Wang J, Zhang Q [..] Wang H-W, Xinquan W, Zhang Z, Zhang L, Zhou Q. Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies |
|
|
S protein of SARS-CoV-2 in complex bound with P2B-1A1 |
2021-03-10 |
|
|
S protein of SARS-CoV-2 in complex bound with P2B-1A10 |
2021-03-10 |
|
|
S protein of SARS-CoV-2 in complex bound with P5A-1B8_2B |
2021-03-10 |
|
|
S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B |
2021-03-10 |
|
|
S protein of SARS-CoV-2 in complex bound with P5A-2G9 |
2021-03-10 |
|
|
S protein of SARS-CoV-2 in complex bound with P5A-1B6_2B |
2021-03-10 |
|
|
S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B |
2021-03-10 |
|
|
S protein of SARS-CoV-2 in complex bound with P5A-2G7 |
2021-03-10 |
|
|
S protein of SARS-CoV-2 in complex bound with P5A-1B9 |
2021-03-10 |
|
|
S protein of SARS-CoV-2 in complex bound with P5A-2F11_2B |
2021-03-10 |
|
|
S protein of SARS-CoV-2 in complex bound with P5A-2F11_3B |
2021-03-10 |
|
|
S protein of SARS-CoV-2 in complex bound with FabP5A-1B8 |
2021-03-10 |
|
|
S protein of SARS-CoV-2 in complex bound with FabP5A-2G7 |
2021-03-10 |
|
|
S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B |
2021-03-10 |
|
|
S protein of SARS-CoV-2 in complex bound with P5A-3A1 |
2021-03-10 |
|
|
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B |
2021-03-10 |
- 同一論文・投稿 (to be publishedを含む)ごとのリストのため、新規公開エントリーより以前に公開されたエントリーも含まれている場合がある。
- カラムTitleは、To be publishedの投稿については仮置であり、ジャーナルからの公開時には変更されている可能性がある。
- Release Dateのカラムの略号など: "AUTH" = PDBでの"編集処理済、登録者の確認・同意待ち"; "HPUB" = PDBでの"論文発表待ち"; "WAIT" = 編集処理開始, 登録者からの連絡待ち; "REPL" = 登録者より新しい座標を受理、再処理が必要; 公開後に更新されたエントリーについては、リスト作成時点での最終更新日を初回公開日に追記。
- 2020年9月2日以前に公開された構造については、PDBj Web siteの新型コロナウイルスの構造情報 全エントリー, または, crisp_bioの過去記事「新型コロナウイルスのPDB公開構造一覧 - その６; その５; その４; その３; その２; その1」参照
- 2020-09-02日以後、PDBの更新に合わせて新規公開分を原則毎週水曜日に投稿
コメント